Page last updated: 2024-08-21

4-hydroxyphenyllactic acid and Alkaptonuria

4-hydroxyphenyllactic acid has been researched along with Alkaptonuria in 3 studies

*Alkaptonuria: An inborn error of amino acid metabolism resulting from a defect in the enzyme HOMOGENTISATE 1,2-DIOXYGENASE, an enzyme involved in the breakdown of PHENYLALANINE and TYROSINE. It is characterized by accumulation of HOMOGENTISIC ACID in the urine, OCHRONOSIS in various tissues, and ARTHRITIS. [MeSH]

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Arnoux, JB; Bou-Gharios, G; Davison, AS; Gallagher, JA; Hughes, AT; Imrich, R; M, K; Milan, AM; Norman, BP; Olsson, B; Ranganath, LR; Rudebeck, M1
Curtis, SL; Gallagher, JA; Milan, AM; Norman, BP; Olsson, B; Ranganath, LR; Roberts, NB1
Jellum, E; Presto Elgstoen, KB1

Other Studies

3 other study(ies) available for 4-hydroxyphenyllactic acid and Alkaptonuria

ArticleYear
Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria.
    Scientific reports, 2022, 09-27, Volume: 12, Issue:1

    Topics: Alkaptonuria; Brain Diseases, Metabolic, Inborn; Cyclohexanones; Homogentisic Acid; Humans; Nitrobenzoates; Phenylalanine; Phenylpropionates; Tyrosine; Tyrosinemias

2022
Interference of hydroxyphenylpyruvic acid, hydroxyphenyllactic acid and tyrosine on routine serum and urine clinical chemistry assays; implications for biochemical monitoring of patients with alkaptonuria treated with nitisinone.
    Clinical biochemistry, 2019, Volume: 71

    Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Alkaptonuria; Cyclohexanones; Enzyme Inhibitors; Humans; Nitrobenzoates; Phenylpropionates; Phenylpyruvic Acids; Tyrosine

2019
Capillary electrophoresis for diagnosis of metabolic disease.
    Electrophoresis, 1997, Volume: 18, Issue:10

    Topics: Alkaptonuria; Electrophoresis, Capillary; Galactosemias; Homogentisic Acid; Homovanillic Acid; Humans; Metabolic Diseases; Neuroblastoma; Phenylpropionates; Vanilmandelic Acid

1997